MGEN - Miragen Therapeutics EPS beats by $0.03 beats on revenue May, 07 2020 04:16 PM Miragen Therapeutics Inc. Miragen Therapeutics (NASDAQ:MGEN): Q1 GAAP EPS of -$0.18 beats by $0.03.Revenue of $0.83M (+124.3% Y/Y) beats by $0.24M.Press ReleaseMore news on: Miragen Therapeutics, Earnings news and commentary, Healthcare stocks news, ,